Early Access

10-QPeriod: Q2 FY2023

ALTRIA GROUP, INC. Quarterly Report for Q2 Ended Jun 30, 2023

Filed August 1, 2023For Securities:MO

Summary

Altria Group, Inc. (MO) reported its second-quarter 2023 financial results, showing a notable increase in net earnings driven by favorable investment results, particularly from its ABI and JUUL investments, alongside effective cost management. The company completed the significant acquisition of NJOY Holdings for $2.9 billion, expanding its presence in the e-vapor market, which is a key component of its "Moving Beyond Smoking" strategy. Despite a slight decrease in net revenues year-over-year, primarily due to lower volumes in its smokeable products segment, Altria demonstrated resilience through pricing strategies and cost control measures. The company's smokeable products segment saw a slight decrease in net revenues and shipment volume, though pricing actions helped offset some of this decline. The oral tobacco products segment experienced growth in net revenues, largely driven by pricing increases and strong performance in the "on!" oral nicotine pouch brand. Altria continues to navigate a challenging macroeconomic environment with persistent inflation, impacting consumer disposable income, but remains focused on its long-term vision of transitioning adult smokers to smoke-free alternatives.

Financial Statements
Beta

Key Highlights

  • 1Net earnings increased significantly year-over-year for both the three and six-month periods, largely due to favorable equity investment results (including the disposition of JUUL and changes in ABI's valuation) and lower interest expenses.
  • 2The company completed the acquisition of NJOY Holdings for $2.9 billion on June 1, 2023, expanding its e-vapor product portfolio, which is a strategic move towards its smoke-free future vision.
  • 3Net revenues saw a slight decrease for the three and six months ended June 30, 2023, compared to the prior year, primarily driven by a decline in the smokeable products segment's shipment volume, though pricing actions partially offset this.
  • 4The oral tobacco products segment reported revenue growth, driven by higher pricing and strong performance in the "on!" oral nicotine pouch brand, which continued its market share momentum.
  • 5Diluted EPS showed a substantial increase for both periods, benefiting from higher net earnings and fewer outstanding shares due to ongoing share repurchases.
  • 6Marketing, administration, and research costs increased significantly, mainly due to acquisition-related costs for NJOY and expenses for resolving JUUL-related litigation and shareholder derivative lawsuits.
  • 7Altria maintained its commitment to returning capital to shareholders, paying $3.365 billion in dividends for the first six months of 2023 and continuing its share repurchase program.

Frequently Asked Questions